ro ru en

State
News
Agency

Process of immunization with Pfizer/BioNTech vaccine to start in Moldova on 23 March

18:30 | 22.03.2021 Category: Social

Chisinau, 22 March /MOLDPRES/ - The process of immunization with the Pfizer/BioNTech vaccine will start on 23 March. The Health, Labour and Social Protection Ministry (MSMPS) has signed an instruction on the distribution of those 12,282 doses of Pfizer/BioNTech vaccine out of the consignment received on 19 March by the territorial Public Health Centres, including in the eastern areas.   

According to the quoted source, the medical employees, as well as other categories of people included in the first vaccination stage will be vaccinated with these doses against COVID-19.

At the same time, an additional training seminar is held today on the vaccination against COVID-19 with the Pfizer/BioNTech vaccine, the conditions of the vaccine’s preservation and administration. Attending the event will be specialists from primary medical assistance institutions, hospitals, public health centres, representatives of the Nicolae Testemitanu State University of Medicine and Pharmacy, as well as of the teams in charge of organizing the vaccination process.   

Pfizer/ BioNTech vaccine needs special conditions of preservation at a temperature from -60 Celsius degrees to -90 degrees. After a controlled process of adjusting the temperature, this vaccine can be transferred and deposited at the normal temperature of the fridge (from +2 to +8 degrees) and the efficiency is preserved for a maximal period of 120 hours and if at least one dose was extracted from the bottle, the latter will be used 6 hours at the most. All vaccinated people will be recorded in the electronic register of COVID-19 vaccination.  

photo: eurointegration.com.ua

 

 

img21002162

Any material published on the website of the Public Institution ’’A.I.S. Moldpres’’ (Moldpres News Agency) is intellectual peoperty of the Agency, protected by the copyright. The taking over or/and use of these materials will be made only with the Agency’s agreement and with compulsory reference to source.